Electrochemical oxidation at a glassy carbon electrode of the anti-arrhythmia drug disopyramide

Analytical Letters

Volumn 40, Issue 15, 2007, Pages 2860-2871

  Diculescu, Victor C ^a   Enache, Teodor Adrian ^a   Oliveira Brett, Ana Maria ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Anti arrhythmic drug; Disopyramide; Oxidation; Voltammetry

Indexed keywords

EID: 35648959787     PISSN: 00032719     EISSN: 1532236X     Source Type: Journal    
DOI: 10.1080/00032710701564151     Document Type: Article

References (26)

1. Abdellatef, H.E. 2007. Extractive-spectrophotometric determination of disopyramideand irbesartan in their pharmaceutical formulation. Spectrochim. Acta A, 66: 1248-1254.
2. Aronson, J.K. 2006. In Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions; The Netherlands: Elsevier, pp. 1145-1148.
3. Bortocan, R., Lanchote, V.L., Cesarino, E.J., and Bonato, P.S. 2000. Enantioselective analysis of disopyramideand mono-N-dealkyldisopyramidein plasma and urine by high-performance liquid chromatography on an amylose-derived chiral stationary phase. J. Chromatogr. B, 744 (2): 299-306.
4. Brett, C.M.A. and Oliveira Brett, A.M. 1993. Electrochemistry. Principles, Methods and Applications; Oxford University Press: UK.
5. Campbell, T.J. 1983. Kinetics of onset of rate-dependent effects of class I antiarrhythmic drugs are important in determining their effects on refractoriness in guineapig ventricle, and provide a theoretical basis for their subclassification. Cardiovasc. Res., 17: 344-352.
6. Coraboeuf, E., Deroubaix, E., Escande, D., and Coulombe, A. 1988. Comparative effects of three class I antiarrhythmic drugs on plateau and pacemaker currents of sheep cardiac Purkinje fibres. Cardiovasc. Res., 22: 375-384.
7. De Lorenzi, F., Bridal, T.R., and Spinelli, W. 1995. Voltage-dependent inhibition of the ATP-sensitive K1 current by the class Ia agent disopyramidein cat ventricular myocytes. J. Pharmacol. Exp. Ther., 272: 714-723.
8. Diculescu, V.C., Vivan, M., and Oliveira Brett, A.M. 2006a. Voltammetric behavior of antileukemia drug glivec. Part I - electrochemical study of glivec. Electroanalysis, 18 (18): 1800-1807.
9. Diculescu, V.C., Vivan, M., and Oliveira Brett, A.M. 2006b. Voltammetric behavior of antileukemia drug glivec. Part II - redox processes of glivec electrochemical metabolite. Electroanalysis, 18 (18): 1808-1814.
10. Fang, L., Yin, X., Sun, X., and Wang, E. 2005. Determination of disopyramidein human urine by capillary electrophoresis with electrochemiluminescence detection of tris(2,2′-bipyridyl) ruthenium (II). Anal. Chim. Acta, 537: 25-30.
11. Hart, J.P. 1990. Electroanalysis of Biologically Relevant Compounds; Ellis Horwood Limited: UK.
12. http://www.hbcpnetbase.com/; Handbook of Chemistry and Physics.
13. Katsu, T. and Mori, Y. 1997. Determination of free disopyramidein blood serum in situ using a disopyramide-sensitive membrane electrode. Anal. Chim. Acta, 343: 79-83.
14. Kuroda, Y., Matsumoto, S., Shibukawa, A., and Nakagawa, T. 2003. Capillary electrophoretic study on pH dependence of enantioselective disopyramidebinding to genetic variants of human α-acid glycoprotein. Analyst, 128: 1023-1028.
15. Kus, T. and Sasyniuk, B.I. 1975. The electrophysiological actions of disopyramidephosphate on canine ventricular muscle and Purkinje fibers. Circ. Res., 37: 844-854.
16. Mayer, F., Kramer, B.K., Ress, K.M., Kuhlkamp, V., Liebich, H.M., Risler, T., and Seipel, L. 1991. Simplified, rapid, and inexpensive extraction procedure for a high-performance liquid chromatographic method for determination of disopyramideand its main metabolite mono-N-dealkylated disopyramidein serum. J. Chromatogr., 572 (1-2): 339-345.
17. Mokler, C.M. and Van Arman, C.G. 1962. Pharmacology of a new antiarrhythmic agent, γ-diisopropyl amino-α-phenyl-α-(2- pyridyl)-butyramide (sc-7031). J. Pharmacol. Exp. Ther., 136: 114-124.
18. Oliveira, S.C.B., Diculescu, V.C., Palleschi, G., Compagnone, D., and Oliveira-Brett, A.M. 2007. Electrochemical oxidation of ochratoxin A at a glassy carbon electrode and in situ evaluation of the interaction with deoxyribonucleic acid using an electrochemical deoxyribonucleic acid-biosensor. Anal. Chim. Acta, 588 (2): 283-291.
19. Quaglio, M.P., Fagioli, F., and Minozzi, L. 1995. Gas chromatographic determination of diisopyramide in the presence of some butyrophenones in human plasma. Boll. Chim. Farm., 134: 34-38.
20. + channel block by disopyramide. J. Pharmacol. Exp. Ther., 290: 515-523.
21. Sherrid, M., Delia, E., and Dwyer, E. 1988. Oral disopyramidetherapy for obstructive hypertrophic cardiomyopathy. Am. J. Cardiol., 62 (16): 1085-1088.
22. Singh, B.N. and Vaughan Williams, E.M. 1970. Classification of anti-arrhythmic drugs. In Symposium on Cardiac Arrhythmias; Sandfte, E., Flensted-Jensen, E. and Olesen, K.H. (eds.); AB ASTRA: Sodertalje, Sweden, 449-472.
23. Taguchi, J., Ohtsuki, S., and Kusu, F. 2003. Voltammetric determination of weak bases based on oxidation of α-tocopherol in an unbuffered solution. J. Electroanal. Chem., 557: 91-97.
24. Vismara, L.A., Mason, D.T., and Amsterdam, E.A. 1974. Disopyramidephosphate: clinical efficacy of a new oral antiarrhythmic drug. Clin. Pharmacol. Ther., 16 (2): 330-335.
25. Witek, A., Zawisza, P., and Przyborowaki, L. 1994. Determination of disopyramidein plasma by high-performance liquid chromatography. J. Pharm. Biomed. Anal., 12 (3): 425-427.
26. + channel blockade: Multiple rest states revealed by channel interactions with disopyramideand quinidine. Am. J. Physiol., 35: H2007-H2017.